Summary: This article will review commonly used clinical trial end-points and describe their potential advantages or disadvantages in exploratory or confirmatory clinical trials in oncology. This review also discusses the problems with study design in case of new targeted biological therapy.
Primary end-points in clinical trials in oncology
- Authors: Doc. MUDr. Regina Demlová, Ph.D.